Weighing in on Optimal Management of VTE in Patients With Obesity


Share

Program Content

  • VTE in Patients With Obesity
    Weighing in on Optimal Management of VTE in Patients With Obesity
    Slideset
    Congratulations: You achieved a completion on 04/09/2022
    View Activity

Supporters

Bristol-Myers Squibb

Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.

Pfizer Alliance

The Bristol Myers Squibb and Pfizer Alliance

Disclosure

This activity is supported by educational grants from the Bristol-Myers Squibb and Pfizer Alliance; and Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.